US Patent 8012931 Modified FGF-21 polypeptides and their uses
Patent 8012931 was granted and assigned to Ambrx on September, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8012931 Modified FGF-21 polypeptides and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
